Xeris Pharmaceuticals | XERS - Işletim Giderleri





Işletim Giderleri Değişiklik Tarih
Celltrion KRW 724.99B 6B 2025-09
Cspc Pharmaceutical CNY 5.4B 298.41M 2025-09
Deva Holding AS TRY 1.35B 178.26M 2023-09
Dianthus Therapeutics USD 40.68M 5.56M 2025-09
Divis Laboratories Ltd INR 18.32B 1.08B 2025-12
Eli Lilly USD 10.31B 1.09B 2025-12
Kangmei Pharma CNY 1.39B 144.29M 2025-09
Knight Therapeutics CAD 118.61M 11.79M 2025-09
Malin Corporation EUR 1.1M 400K 2024-12
Medical Developments International AUD 21.61M 11.59M 2025-12
Nektar Therapeutics USD 85.09M 109.3M 2025-09
Neuren Pharmaceuticals AUD 25.23M 16.54M 2025-12
Organigram Holdings CAD 108.11M 17.03M 2025-09
Ovoca Bio EUR 5.65M 3.45M 2022-06
Pacira USD 193.68M 27.32M 2025-12
Perrigo USD 1.03B 75.3M 2025-12
Pharma Mar EUR 46.87M 7.24M 2025-12
Qiagen NV USD 418.54M 23.25M 2025-12
Sartorius EUR 693.1M 29.4M 2025-09
Sino Biopharmaceutical CNY 12.39B 1.26B 2025-06
Supernus Pharmaceuticals USD 197.75M 54.54M 2025-12
Tilray USD 237.52M 17.34M 2025-09
Zz Pientze Pharmaceu CNY 1.55B 129.66M 2025-09